文献速递生殖医学妇科

绝经后女性卵巢皮质细胞体外分化为膜细胞的研究

In vitro differentiation of theca cells from ovarian cells isolated from postmenopausal women.
PubMed 文献 · Hum Reprod · 2020-01-01

该研究从8名绝经后女性(53-74岁)的卵巢皮质分离基质细胞,在含生长因子、FSH和LH的培养基中体外培养8天,通过qPCR、免疫组化、电镜和ELISA证实了人膜细胞(TCs)的体外分化,并检测到DHEA和孕酮水平变化。

要点

  • 绝经后卵巢皮质细胞可在含生长因子、FSH和LH的培养基中体外分化为膜细胞。
  • 分化细胞表达Lhr、Cyp17a1、Hsd3b2等类固醇生成相关基因及CD13、NOTCH1等蛋白标志物。
  • 培养期间DHEA浓度随时间显著增加,提示类固醇生成功能获得。

核心结论

  • 人膜细胞可在体外从绝经后卵巢皮质分离的细胞中分化获得。

研究设计与样本

  • 研究纳入8名因妇科非卵巢疾病行腹腔镜手术的绝经后女性(53-74岁),取卵巢活检。
  • 分离卵巢皮质基质细胞,体外培养8天,分4组:基础培养基(G1)、含生长因子FSH和LH的塑料基质(G2)、胶原基质无颗粒细胞系(G3)、胶原基质有颗粒细胞系(G4)。

主要发现

  • qPCR显示Lhr mRNA在F2和G4中显著增加(P<0.05),Cyp17a1在G1和F1中显著增加(P<0.05),Hsd3b2在G1、G2、G3和G4中显著增加(P<0.05)。
  • 免疫组化证实类固醇生成通路各酶在蛋白水平表达;除G1外,其余组CD13阳性细胞数显著增加(P<0.05);G3和G4中NOTCH1阳性细胞显著增加(P<0.05)。
  • 透射电镜显示各组超微结构存在差异;培养期间G1、G2、G3和G4中DHEA浓度随时间显著增加(q<0.001),G2、G3和G4中孕酮水平显著增加(q<0.001),G1孕酮水平保持不变。

临床怎么用

  • 体外生成的人膜细胞可用于药物筛选研究。
  • 该模型有助于理解膜细胞相关病理,如雄激素分泌肿瘤和多囊卵巢综合征。

局限性

  • 较短的培养时间(如2、4、6天)可能增加G2、G3和G4中分化膜细胞的浓度。
  • 需设置基础培养基联合COV434细胞的组别以明确其在分化中的作用。
  • 尚不清楚细胞是来源于卵巢皮质中前体膜细胞亚群还是一般基质细胞,需鉴定前体膜细胞特异性标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can human theca cells (TCs) be differentiated in vitro? SUMMARY ANSWER: It is possible to differentiate human TCs in vitro using a medium supplemented with growth factors and hormones. WHAT IS KNOWN ALREADY: There are very few studies on the origin of TCs in mammalian ovaries. Precursor TCs have been described in neonatal mice ovaries, which can differentiate into TCs under the influence of factors from oocytes and granulosa cells (GCs). On the other hand, studies in large animal models have reported that stromal cells (SCs) isolated from the cortical ovarian layer can also differentiate into TCs. STUDY DESIGN, SIZE, DURATION: After obtaining informed consent, ovarian biopsies were taken from eight menopausal women (53-74 years of age) undergoing laparoscopic surgery for gynecologic disease not related to the ovaries. SCs were isolated from the ovarian cortex and in vitro cultured for 8 days in basic medium (BM) (G1), enriched with growth factors, FSH and LH in plastic (G2) or collagen substrate without (G3) or with (G4) a GC line. PARTICIPANTS/MATERIALS, SETTING, METHODS: To confirm TC differentiation, relative mRNA levels for LH receptor (Lhr), steroidogenic acute regulatory protein (Star), cholesterol side-chain cleavage enzyme (Cyp11a1), cytochrome P450 17A1 (Cyp17a1), hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (Hsd3b1) and hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (Hsd3b2) were assessed. Immunohistochemistry was also performed for their protein detection and a specific marker was identified for TCs (aminopeptidase-N, CD13), as were markers for theca and small luteal cells (dipeptidyl peptidase IV (CD26) and Notch homolog 1, translocation-associated (NOTCH1)). Finally, we analyzed cell ultrastructure before (Day 0) and after in vitro culture (Day 8), and dehydroepiandrosterone (DHEA) and progesterone levels in the medium using transmission electron microscopy (TEM) and ELISA, respectively. MAIN RESULTS AND THE ROLE OF CHANCE: Results obtained from qPCR showed a significant increase (P < 0.05) in mRNA levels of Lhr in F2 (floating cells in G2) and G4, Cyp17a1 in G1 and F1 (floating cells in G1) and Hsd3b2 in G1, G2, G3 and G4. Immunohistochemistry confirmed expression of each enzyme involved in the steroidogenic pathway at the protein stage. However, apart from G1, all other groups exhibited a significant (P < 0.05) rise in the number of CD13-positive cells. There was also a significant increase (P < 0.05) in NOTCH1-positive cells in G3 and G4. Ultrastructure analyses by TEM showed a distinct difference between groups and also versus Day 0. A linear trend with time revealed a significant gain (q < 0.001) in DHEA concentrations in the medium during the culture period in G1, G2, G3 and G4. It also demonstrated a statistical increase (q < 0.001) in G2, G3 and G4 groups, but G1 remained the same throughout culture in terms of progesterone levels. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Shorter periods of in vitro culture (e.g. 2, 4 and 6 days) could have led to increased concentrations of differentiated TCs in G2, G3 and G4. In addition, a group of cells cultured in BM and accompanied by COV434 cells would be necessary to understand their role in the differentiation process. Finally, while our results demonstrate that TCs can be differentiated in vitro from cells isolated from the cortical layer of postmenopausal ovaries, we do not know if these cells are differentiated from a subpopulation of precursor TCs present in ovarian cortex or ovarian SCs in general. It is therefore necessary to identify specific markers for precursor TCs in human ovaries to understand the origin of these cells. WIDER IMPLICATIONS OF THE FINDINGS: This is a promising step toward understanding TC ontogenesis in the human ovary. Moreover, in vitro-generated human TCs can be used for studies on drug screening, as well as to understand TC-associated pathologies, such as androgen-secreting tumors and polycystic ovary syndrome. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grants from the Fonds National de la Recherche Scientifique de Belgique (FNRS) (C.A.A. is an FRS-FNRS Research Associate; grant MIS #F4535 16 awarded to C.A.A.; grant 5/4/150/5 awarded to M.M.D.; grant ASP-RE314 awarded to P.A.) and Foundation Against Cancer (grant 2018-042 awarded to A.C.). The authors declare no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Asiabi P, Dolmans MM, Ambroise J, et al. In vitro differentiation of theca cells from ovarian cells isolated from postmenopausal women. Hum Reprod. 2020. PMID: 33326997. doi:10.1093/humrep/deaa246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。